Gli altri portali
Notizie
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Mycosis Fungoides Market Set to Expand by 2034 with Advancements in Targeted and…
Mycosis Fungoides Market Summary Mycosis Fungoides Market Summary Discover the mycosis fungoides new treatment @New Treatments for Mycosis Fungoides Key Factors Driving the Growth of the Mycosis Fungoides Market Increasing Prevalence of Mycosis Fungoides The mycosis fungoides market is expanding due to a rising number of mycosis fungoides cases, which is the most common type of cutaneous T-cell lymphoma. Studies have shown a steady increase in the incidence of this...
PR Newswire
26/11/2025
Bavarian Nordic to Host a Shareholder Information Meeting on December 11, 2025…
COPENHAGEN, Denmark, November 26, 2025– Bavarian Nordic A/S invites its shareholders for a meeting and dialogue with the company’s board and management, who will provide the state of business and give a recap of the company’s strategy.The meeting will take place at Tivoli Hotel & Congress Center, Arni Magnussons Gade 2, DK-1577 Copenhagen V, Denmark on December 11, 2025 from 09:00 am to 10:30 am CET. The meeting will be held in English.Anyone who is registered as a shareholder in...
Nasdaq GlobeNewswire
26/11/2025
Piramal Pharma Solutions Achieves Regulatory Compliance for Nitrosamine…
The first step of this proactive approach involved the development of a cross-functional core team comprised of subject matter experts from Regulatory Affairs, Central Quality, R&D, and Manufacturing. These experts offered specialized insights from their unique perspective, interpreted regulatory guidance as it was published, and ensured every operation across our organization remains compliant with international NDSRI guidelines. The first step of this proactive approach involved the...
PR Newswire
26/11/2025
Metered Dose Inhalers Market to Reach $18.4 billion, Globally, by 2034 at 6.2%…
MDIs are popular across hospitals, clinics, and home care settings due to their portability, ease of use, and effective drug delivery mechanism. The increasing global burden of respiratory diseases, rising air pollution levels, growing geriatric population, and advancements in inhaler technology are driving the adoption of MDIs. The market is further supported by innovations such as breath-actuated MDIs and the integration of dose counters to enhance treatment compliance and monitoring. MDIs...
PR Newswire
26/11/2025
Valneva to Further Consolidate its Operations in France
French operations to be concentrated at its Lyon site Final consolidation of R&D in Vienna Saint-Herblain (France), November 26 , 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced a strategic initiative to optimize its organizational footprint in France as part of the Company’s ongoing efforts to increase operational effectiveness and position Valneva for long-term success. The Company plans to concentrate its French operations...
Nasdaq GlobeNewswire
26/11/2025
Spinal Implants And Surgery Devices Market is expected to generate a revenue of…
For a detailed analysis of Industry Trends And Growth Drivers, Explore The Full Spinal Implants And Surgery Devices Market. For a detailed analysis of Industry Trends And Growth Drivers, Explore The Full Spinal Implants And Surgery Devices Market . Browse in-depth TOC 202 – Pages 126 – Tables 37 – Figures Global Spinal Implants And Surgery Devices Market Overview Market Driver 1. Rising Prevalence of Degenerative Spinal Disorders 2. Increased...
PR Newswire
26/11/2025
Airway Management Devices Market to Reach USD 3.82 Billion by 2031 as Global…
Download PDF Brochure: https://www.datamintelligence.com/download-sample/airway-management-devices-market Download PDF Brochure:https://www.datamintelligence.com/download-sample/airway-management-devices-market Browse in-depth TOC on 'Airway Management Devices Market' 62 – Tables 59 – Figures 159 – Pages A New Era of Respiratory Stabilization: Why the Market Is Strengthening 1. Rising Respiratory Disease Burden Over544 million people worldwidelive with...
PR Newswire
26/11/2025
Gummy Supplements Market to Reach USD 66.79 Billion by 2031 as Consumer Shift…
The market's growth is further amplified by rising lifestyle-related deficiencies, expanding preventive healthcare initiatives, social media–driven wellness culture, and the strong uptake of personalized nutrition products. The market's growth is further amplified by rising lifestyle-related deficiencies, expanding preventive healthcare initiatives, social media–driven wellness culture, and the strong uptake of personalized nutrition products. Download PDF Brochure:https://www...
PR Newswire
26/11/2025
Intraocular Lens Market worth $6.17 billion by 2030 with 6.0% CAGR |…
Browse in-depth TOC on "Intraocular Lens Market" 222 - Tables 50 - Figures239 - Pages Browse in-depth TOC on "Intraocular Lens Market" 222 - Tables50 - Figures 239 - Pages By Type,Aspheric monofocal IOLs hold the largest market share because they offer reliable visual outcomes, improved contrast sensitivity, and reduced spherical aberrations at an affordable cost. Their strong clinical performance, wide surgeon preference, and broad reimbursement coverage make...
PR Newswire
26/11/2025
Mural Health Expands Offering to Include Meal Delivery Services for Clinical…
"At Mural Health, we are continually looking for new ways to remove friction from the participant experience," said Sam Whitaker, Co-Founder & CEO of Mural Health. "Introducing meal delivery services is a natural extension of that commitment. By helping ensure participants have access to nutritious meals of their choice, we're reducing yet another burden that can make trial participation difficult, and reinforcing our belief that every participant deserves care and…
PR Newswire
26/11/2025
BioNTech Shares Progress on Exchange Offer for CureVac Shares and Highlights…
Offer set to expire at 9:00 am Eastern Time on December 3, 2025, with CureVac shareholders advised to tender their shares by 6:00 pm Eastern Time on December 2, 2025, due to operational deadlines.Exchange ratio of 0.05363 of a BioNTech American Depositary Share (“ADS”) for each CureVac share, determined based on the volume-weighted average price of BioNTech ADSs over the 10 trading days ending November 25, 2025.CureVac shareholders approved matters related to BioNTech’s exchange...
Nasdaq GlobeNewswire
26/11/2025
Oral Care Market Poised to Grow to USD 86.8 Billion by 2035 with a Thriving CAGR…
The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report @ https://www.vantagemarketresearch.com/oral-care-market-1650/request-sample The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report @ https://www.vantagemarketresearch.com/oral-care-market-1650/request-sample Free Sample Includes: Oral Hygiene Moves from Routine to Intelligent Wellness The oral care ecosystem is undergoing a...
PR Newswire
26/11/2025
Kanazawa University research: Scientists develop light-controlled method to…
The team led by Satoshi Arai demonstrated that embedding vanadium phthalocyanine dye (VPc) into liposome membranes allows light-induced local heating confined at the molecular level (Figure1). Unlike conventional temperature-sensitive liposomes, which rely on bulk heating, this approach enables reversible and highly localized release of cargo molecules without causing widespread thermal damage. The team led bySatoshi Araidemonstrated that embedding vanadium phthalocyanine dye (VPc) into...
PR Newswire
26/11/2025
Tangram Therapeutics Submits Clinical Trial Application for Phase 1/2 Study of…
The Company expects to initiate first-in-human study in early 2026, with initial data anticipated H2 2026Clinical Trial Application (CTA) submission marks the advancement of Tangram’s GalOmic RNAi platform into clinical development LONDON, Nov.26, 2025(GLOBE NEWSWIRE) -- Tangram Therapeutics (‘Tangram’), a company committed to uniting computation and RNAi to make better medicines faster, today announced the submission of a Clinical Trial Application (CTA) to the Medicines and...
Nasdaq GlobeNewswire
26/11/2025
mAIbe and LenioBio announce a new strategic collaboration aimed at accelerating…
LenioBio's ultrafast, scalable expression system enables rapid production of complex antibodies, providing high-quality experimental data that feeds directly into mAIbe's AI models. LenioBio's ultrafast, scalable expression system enables rapid production of complex antibodies, providing high-quality experimental data that feeds directly into mAIbe's AI models. Through this integrated approach, the two teams will jointly: Together, mAIbe and LenioBio set a new standard for speed,...
PR Newswire
26/11/2025
InnotiveDx Wins £1 million Grant From PACE
InnotiveDx has demonstrated that its underlying UTI diagnostic technology can provide extremely accurate Bacterial ID and antimicrobial susceptibility test (AST) results in less than 60 minutes, with its benchtop assay accuracy exceeding 96% in blinded evaluations. InnotiveDx has transitioned this technology into fully working, automated prototypes. The £1m PACE grant will allow InnotiveDx to fully assess the accuracy and reliability of these prototype systems with thousands of clinical…
PR Newswire
26/11/2025
Sectra launches its built-in reporting solution in the US--accelerates…
Sectra Reporting is a native, built-in solution that streamlines diagnostic workflows by integrating directly with imaging data and measurements. To free up time for the radiologist to focus on diagnostics rather than on documentation, the solution has AI capabilities such as automated impression generation and external AI results seamlessly integrated. At the same time, deep links to measurements, annotations, and lesion-tracking data allow radiologists to embed precise, actionable references…
PR Newswire
26/11/2025
Flagship Foldable Phone to Highlight Huawei's Product Launch in Dubai
Huawei launched its first foldable phone, HUAWEI Mate X in 2019, and in the seven years since has led the way in foldable technology, driving innovations in design, reliability, and user experience. The company held a 70% market share in China's foldable phone market in the first half of 2025, according to an International Data Corporation (IDC) report, ranking first with over ten million devices shipped. HUAWEI Mate X7 features trailblazing dual-fold technology, enhanced reliability, along with…
PR Newswire
26/11/2025
Curasight's uTREAT® Phase 1 Trial in Brain Cancer Now Open for Patient…
The phase 1 trial is part of Curasight's theranostic strategy developing more gentle and targeted diagnosis and treatment of certain types of cancer. The phase 1 trial is part of Curasight's theranostic strategy developing more gentle and targeted diagnosis and treatment of certain types of cancer. "It is a very exciting stage in the development of uTREAT, that we are now ready to enroll patients and progress the development of uTREAT as a potential more targeted therapeutic solution for...
PR Newswire
26/11/2025
Nyxoah’s Genio® Therapy Receives Significant 2026 Medicare Reimbursement…
Nyxoah’s Genio® Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule Assignment to New Technology APC 1580 is positive news for Nyxoah’s U.S. commercial rollout by strengthening hospital and ASC economics Mont-Saint-Guibert, Belgium – November 26, 2025, 7:45 am CET / 1:45 am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep...
Nasdaq GlobeNewswire
26/11/2025
Galapagos Receives Transparency Notifications from Bank of America
Mechelen, Belgium; November 26, 2025, 07:30 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received transparency notifications from Bank of America. Pursuant to Belgian transparency legislation 1, Galapagos received transparency notifications on November 18 and November 19, 2025, from Bank of America Corporation indicating that it positively crossed the threshold of 5% of Galapagos’ voting rights on November 12, 2025 following an acquisition of Galapagos’...
Nasdaq GlobeNewswire
26/11/2025
Valneva Announces Positive Final Phase 2 Results for Lyme Disease Vaccine…
Antibody levels remained well above baseline across all six serotypes and age groups sixth month after third yearly booster doseNo safety concerns observed in any age group by an independent Data Monitoring Committee (DMC)Results confirm benefits of a yearly vaccination prior to each Lyme season Saint-Herblain (France), November 26, 2025– Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced positive final immunogenicity and safety data from Phase 2 study, VLA15-221,...
Nasdaq GlobeNewswire
26/11/2025
Kuros Biosciences to present at the Piper Sandler 37th Annual Healthcare…
Kuros Biosciences to present at the Piper Sandler 37 thAnnual Healthcare Conference Schlieren (Zürich), Switzerland, November 26, 2025– Kuros Biosciences (“Kuros” or the “Company”) a leader in innovative biologic technologies, will present at the Piper Sandler 37th Annual Healthcare Conference, taking place December 2–4, 2025 at The Lotte New York Palace in New York City.The Company’s presentation will highlight continued commercial momentum, clinical advancement across the...
Nasdaq GlobeNewswire
26/11/2025
Mitochondrial Myopathies Market to Register Stunning Growth at a CAGR of 26.5%…
Mitochondrial Myopathies Market Summary Mitochondrial Myopathies Market Summary Discover the new mitochondrial myopathies treatment @ Mitochondrial Myopathies Treatment Market Key Factors Driving the Growth of the Mitochondrial Myopathies Market Improved diagnostics and expanding genetic testing Wider availability of next-generation sequencing, broader use of whole-exome/genome testing and improved clinical awareness are increasing diagnosis rates and enabling patient...
PR Newswire
25/11/2025
Altri Comunicati
